Is Cineplex Inc. (TSX:CGX) Stock on a Super Sale?

Cineplex Inc. (TSX:CGX) fell +20% on Wednesday. Is its +6% dividend yield safe? Is it a big bargain? What’s the upside potential?

| More on:
edit Businessman using calculator next to laptop

Image source: Getty Images.

Cineplex (TSX:CGX) generates most of its revenues from its box office and related sales, which are affected by attendance levels. Unfortunately, the number of moviegoers has been on a general decline with occasional spikes in quarters in which there are attractive movies.

In the first nine months of the year, Cineplex’s box office revenues were $542.1 million, or 45.7% of total revenues, while its concession revenues were $329.9 million or 27.8% of total revenues. So, about 73.5% of revenues relied on people to go to the movies.

Just how bad were Cineplex’s third-quarter results to trigger the stock to fall nearly 21% on Wednesday?

A stock price graph showing declines
Image source: Getty Images.

What was alarming about Cineplex’s Q3 results?

In Q3, Cineplex saw modest growth of 4.4% and 2.6%, respectively, in its total revenues and theatre attendance. What stood out like a sore thumb were declines of -40.7%, -9.3%, and -40.7%, respectively, in net income, adjusted EBITDA, and diluted earnings per share compared to the same period in 2017. Not quite as alarming, albeit still not pleasing was adjusted free cash flow decline of -3.7% and a decline of -3.5% on a per-share basis.

Management explained that “adjusted EBITDA declined $5.5 million to $53.4 million mainly due to an increase in the share-based compensation cost as compared to the prior year ($8.4 million) due to the decline in the share price in 2017 compared to the increase in the share price in 2018.”

The decline in net income and earnings per share had partly to do with increased costs of about 8%. Key items include film cost increasing by 8.3% to $90.2 million, non-cash depreciation and amortization increasing by 9.8% to $33.6 million, and other costs climbing 6.9% to $218.9 million.

The first nine months

Reviewing Cineplex’s nine-month results show a more normalized and healthier picture of the business. Although theatre attendance declined marginally, moviegoers have been spending more on their movie tickets and theatre food and drinks.

Here are some key metrics compared to the same period in 2017:

Q1-Q3 2017 Q1-Q3 2018 Change
Total revenues $1,128.8 million $1,186.6 million 5.1%
Theatre attendance 52,843 52,280 -1.1%
Net income $41.6 million $49.8 million 19.8%
Box office revenues per patron $10.04 $10.37 3.3%
Concession revenues per patron $5.90 $6.31 6.9%
Adjusted EBITDA $156.3 million $174.7 million 11.8%
Adjusted EBITDA margin 13.8% 14.7% 0.9%
Adjusted free cash flow per share $1.563 $1.874 19.9%
Diluted earnings per share $0.66 $0.79 19.7%

Is Cineplex’s dividend safe? 

Cineplex’s monthly dividend per share is almost 3.6% higher than it was a year ago. Its annualized payout is $1.74 per share, which equates to a juicy yield of nearly 6.1% at the market close price of $28.56 per share.

Its adjusted free cash flow payout ratio in the first nine months was 63.5%, compared to 75.3% in the same period of 2017. So, Cineplex’s dividend is safer than it was before.

Investor takeaway 

The increased overall costs in Q3 is a concern. Will it be a trend and continue into the future? The change in costs is something that investors should keep an eye on.

Other than that, investors should also keep tabs on the changes in theatre attendance, box office revenues per patron, and concession revenues per patron to ensure Cineplex’s core business remains healthy.

Cineplex’s +6% yield seems safe. At $28.56, it trades at about 8.6 times estimated 2018 cash flow, which is about a 20% discount from its normal levels. The analyst consensus from Thomson Reuters has a 12-month target of $36.30 per share on the stock, representing a discount of about 21% or near-term upside potential of about 27%.

In conclusion, Cineplex is not quite on a super sale, but it’s trading at a moderate discount.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Kay Ng has no position in any of the stocks mentioned.

More on Dividend Stocks